Towards successful management of allergic rhinitis and advocating for a paradigm shift

01 Jun 2024
Towards successful management of allergic rhinitis and advocating for a paradigm shift
At the recent Allergic March Symposium, Dr Kent Woo, Consultant Allergist and Immunologist, Immediate Past President of Malaysian Society of Allergy and Immunology, and Professor Dr David Price, Founder and Managing Director, Observational & Pragmatic Research Institute (Singapore) and Optimum Patient Care (Australia, Singapore and UK), University of Aberdeen (Scotland, UK), spoke on the topic of allergy, atopic march, allergic rhinitis and the importance of comprehensive symptom management in the paediatric setting.
Sponsored as an educational program by Mylan Healthcare Sdn. Bhd.(a Viatris Company)

Related MIMS Drugs

Resources

MY-PFO-017

MY-PFO-017

MY-PFO-017

MY-PFO-017